Shareholding disclosure

Astellas Pharma Inc

Declared position

4.44%

Threshold

Crossed upwards

Timeline

Published

02.09.2016

Transaction

13.06.2016

Voting rights breakdown

Voting rights acquired4.44%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAG8V00054

Beneficial owner

Astellas Pharma Inc

Declared address

Astellas Pharma Inc., 103-8411 Tokyo

Astellas Venture Capital LLC sold 10'000 shares of HBM Healthcare Investments AG on June 13, 2016, which triggered the obligation to notify below 5% shareholding. Astellas Venture Capital LLC which is a 99.9% subsidiary of Astellas US Holding, Inc.,1 Astellas Way Northbrook, IL 60062, which is wholly owned subsidiary of Astellas Pharma Inc., Japan. (beneficial owner)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Astellas Pharma Inc

HBM Healthcare Investments AG02.09.2016TAG8V00054

Disclosure summary

Astellas Pharma Inc disclosed a holding in HBM Healthcare Investments AG on the acquisition side, published by SIX Exchange Regulation on 02.09.2016, at 4.44% of voting rights. Notice category: Single shareholder.

Disclosed position

4.44%

Voting rights acquired

Voting rights acquired4.44%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Astellas Pharma Inc disclosed a holding in HBM Healthcare Investments AG, published on 02.09.2016.

Publication date02.09.2016

Transaction date13.06.2016

Issuing companyHBM Healthcare Investments AG

Beneficial ownerAstellas Pharma Inc

Declared addressAstellas Pharma Inc., 103-8411 Tokyo

CategorySingle shareholder

Voting rights acquired4.44%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAG8V00054

Conditions

Astellas Venture Capital LLC sold 10'000 shares of HBM Healthcare Investments AG on June 13, 2016, which triggered the obligation to notify below 5% shareholding. Astellas Venture Capital LLC which is a 99.9% subsidiary of Astellas US Holding, Inc.,1 Astellas Way Northbrook, IL 60062, which is wholly owned subsidiary of Astellas Pharma Inc., Japan. (beneficial owner)

Source: SIX Exchange Regulation · Publication date: 02.09.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open